Viewing Study NCT07145918


Ignite Creation Date: 2025-12-25 @ 4:30 AM
Ignite Modification Date: 2026-01-28 @ 11:51 PM
Study NCT ID: NCT07145918
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schizophrenia View
None ABBV-1231 View